LUNIT INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 52,300 KRW | -2.61% |
|
+6.73% | -36.14% |
| Apr. 16 | Lunit Wins Shareholder Approval for Volpara Health Takeover | MT |
| Apr. 12 | Volpara Health Technologies Secures Approval for Lunit’s Proposed Takeover | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Lunit Inc is a Korea-based company principally engaged in the development and supply of medical software. The Company is principally engaged in the development and supply of medical software such as cancer diagnostic aid solutions, cancer early detection solutions, cancer risk prediction solutions and others through artificial intelligence (AI) technologies.
Calendar
2024-08-10
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
52,300
KRW
Average target price
100,000
KRW
Spread / Average Target
+91.20%
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -36.14% | 1.09B | |
| +4.36% | 32.47B | |
| +14.14% | 7.45B | |
| +22.93% | 3.89B | |
| -16.29% | 3.15B | |
| -25.96% | 1.28B | |
| -35.42% | 902M | |
| -0.13% | 893M | |
| -24.12% | 857M | |
| -18.47% | 693M |
- Stock Market
- Equities
- A328130 Stock
- News Lunit Inc.
- GC Cell Signs Agreement with Lunit for AI-Powered Cancer Treatment
